Management of Pancreatic Cancer and Cholangiocarcinoma

Part I Current topics in Epidemiology and Examinations of Pancreatic Cancer and Cholangiocarcinoma 1 Risk Factors for Pancreatic Cancer and Cholangiocarcinoma 2 Detection strategies and examination of early pancreatic cancer 3 Biomarkers for Pancreatic Cancer and Cholangiocarcinoma 4 Recent advances of precision medicine in pancreatic cancer and and cholangiocarcinoma Part II Anti-cancer Treatments for Pancreatic Cancer 5 Chemotherapy for locally advanced and metastatic pancreatic cancer 6 Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer 7 Adjuvant Chemotherapy for Pancreatic Cancer 8 Conversion Surgery in Pancreatic Cancer 9 Radiotherapy for pancreatic cancer Part III Anti-cancer Treatments for Cholangiocarcinoma 10 Chemotherapy for Unresectable Cholangiocarcinoma 11 Adjuvant chemotherapy for cholangiocarcinoma 12 Neoadjuvant therapy and conversion surgery for cholangiocarcinoma 13 Radiotherapy for Cholangiocarcinoma Part IV New Treatment for Pancreatic Cancer and Cholangiocarcinoma 14 Precision medicine for pancreatic cancer and cholangiocarcinoma 15 Immunotherapy for pancreatic cancer and biliary tract cancer 16 Treatment approach for pancreatic ductal adenocarcinoma with peritoneal dissemination 17 Treatment strategies for frail and elderly patients with pancreatic cancer Part V Endoscopic Management of Pancreatic Cancer and Cholangiocarcinoma 18 Endoscopic diagnosis of pancreatic cancer and cholangiocarcinoma 19 Preoperative biliary drainage for pancreatic cancer and cholangiocarcinoma 20 ERCP for malignant biliary obstruction for unresectable pancreatic cancer and cholangiocarcinoma 21 Interventional EUS for pancreatic cancer and cholangiocarcinoma 22 Novel endoscopic focal therapy for pancreatic cancer and cholangiocarcinoma 23 Endoscopic management of gastrointestinal obstruction from pancreaticobiliary cancer 24 Development of Self-expandable Biliary Metal Stents for Pancreatic Cancer and Cholangiocarcinoma

This comprehensive book presents the latest evidence-based data on pancreatobiliary malignancies, including the epidemiology, examination, treatment and endoscopic management. It explores a range of topics, such as risk factors, detection strategies, and novel treatment approaches like precision medicine and immunotherapy.

Although there have been rapid improvements in the management of these diseases, the survival period has not yet reached a satisfactory level. This book will help those doctors needing to share the latest information with the patients and their families. It provides a wealth of practical information to help surgeons, endoscopists and oncologists as well as physicians, basic researchers and professionals at medical device and pharmaceutical companies broaden their understanding of the current treatment and management strategies for pancreatobiliary malignancies.

Author Information

Hiroyuki Isayama
Department of Gastroenterology,
Graduate School of Medicine, Juntendo University Tokyo, Japan.
h-isayama@juntendo.ac.jp

Yousuke Nakai
Department of Endoscopy and Endoscopic Surgery,
Graduate School of Medicine, The University of Tokyo,
Tokyo, Japan
ynakai-tky@umin.ac.jp

Takashi Sasaki
Department of Hepato-Biliary-Pancreatic Medicine,
Cancer Institute Hospital of Japanese Foundation for Cancer Research,
Tokyo, Japan
sasakit-tky@umin.ac.jp